circle
Earth BioGenome Project Phase 2 (EBP2)
Goals of EBP Phase 2 is to complete high-quality reference genome sequencing for 150,000 species within five years, covering at least 50% of known eukaryotic genera, while prioritizing species of significant value to ecological conservation, food security, disease prevention and control, and the biotech industry. Upon completion of this phase, EBP will encompass approximately one-tenth of known eukaryotic biodiversity on Earth, laying the foundation for Phase 3.
EBP2 Progress
61 / 60
CLASS
185 / 238
ORDER
507 / 879
FAMILY
1,566 / 6,701
GENUS
6,975
SPECIES
8,263
NCBI GENUS
Core QC metrics
MinimumMedianMaximumAverage
Genome size330.78Kb 33.81Mb (n=6,974) 2.05Gb38.36Mb
Contig N50130 183.88Kb (n=6,974) 37.09Mb813.90Kb
Scaffold N50133 278.41Kb (n=6,961) 60.21Mb1.06Mb
GC percentage (%)16.5 49 (n=6,974) 68.548
ClassNumber of EBP2 target genusNumber of sequenced genusNumber of pending genusCoverage
sordariomycetes1,38301,383
dothideomycetes1,32901,329
agaricomycetes1,20801,208
lecanoromycetes6530653
leotiomycetes5020502
Records per page:
1-5 of 60
Implementation Roadmap
  1. Collect samples from 300,000 species worldwide
  2. Select 150,000 of these for high-quality reference genome sequencing
  3. Total core project investment of approximately US$1.1 billion
Global Division of Labor

EBP2 will be jointly advanced by multiple regional centers, with plans to establish approximately 25 regional nodes worldwide. Each node will collect samples from approximately 12,000 species and complete the sequencing and assembly of approximately 6,000 species.

EBP group

Group Photo at the EBP2 Launch Meeting (May 2026, Canada)

For the EBP China Center partnership recruitment initiative and detailed information, please see this page.